Last reviewed · How we verify
Inactivated Influenza Vaccine of GSK — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Inactivated Influenza Vaccine of GSK (Inactivated Influenza Vaccine of GSK) — Hualan Biological Engineering, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Inactivated Influenza Vaccine of GSK TARGET | Inactivated Influenza Vaccine of GSK | Hualan Biological Engineering, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Inactivated Influenza Vaccine of GSK CI watch — RSS
- Inactivated Influenza Vaccine of GSK CI watch — Atom
- Inactivated Influenza Vaccine of GSK CI watch — JSON
- Inactivated Influenza Vaccine of GSK alone — RSS
Cite this brief
Drug Landscape (2026). Inactivated Influenza Vaccine of GSK — Competitive Intelligence Brief. https://druglandscape.com/ci/inactivated-influenza-vaccine-of-gsk. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab